Results 51 to 60 of about 1,137 (206)
The aim of the present study was to bring additional evidence regarding a biopredictive dissolution medium containing 1% sodium lauryl sulphate (SLS) to predict the in vivo behavior of carbamazepine (CBZ) products.
Marival Bermejo +5 more
doaj +1 more source
Buspirone Hydrochloride Polymorphism: Stability, Solubility, Flow Properties, and Manufacturing Implications. [PDF]
Buspirone hydrochloride, an anxiolytic agent, has two interconvertible polymorphic forms that may affect its physicochemical properties and therapeutic efficacy. Despite this relevance, polymorphism is often neglected in pharmaceutical analyses, potentially leading to inconsistent results and compromised drug performance.
Janning JA +7 more
europepmc +2 more sources
Challenges and Opportunities to Use Biowaivers to Compare Generics in China [PDF]
Biowaivers for class I drugs according to the biopharmaceutics classification system (BCS) were first introduced in 2000. The in vitro equivalence can be used to document bioequivalence between products. This study compared the in vitro dissolution behavior of two BCS class I drugs, amoxicillin and metronidazole, which are sold in China.
Jieyu, Zuo +3 more
openaire +2 more sources
On the BCS biowaivers of orally disintegrating tablets
A recent paper in this journal by Ono and Sugano (2014) suggests BCS-based biowaivers can be applied to assess the bioequivalence of orally disintegrating tablets (ODTs) with immediate release formulations for Class III drugs. The assertion made by the paper is a concern for us for reasons including the following: the supposition has not been tested ...
Alfredo García-Arieta, John Gordon
openaire +2 more sources
Biowaiver based on the biopharmaceutics classification system (BCS) has been widely used in the global market for the approval of new generic drug products to avoid unnecessary in vivo bioequivalence (BE) studies.
Xian Zhang (191440) +7 more
core +1 more source
Biowaiver monographs for immediate release solid oral dosage forms: Aciclovir [PDF]
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing (biowaiver) for the approval of immediate release (IR) solid oral dosage forms containing aciclovir are reviewed.
Arnal, J. +21 more
core +1 more source
In Vitro Dissolution and in Silico Modeling Shortcuts in Bioequivalence Testing
Purpose: To review in vitro testing and simulation platforms that are in current use to predict in vivo performances of generic products as well as other situations to provide evidence for biowaiver and support drug formulations development.
Moawia M. Al-Tabakha, Muaed J. Alomar
doaj +1 more source
Utility of Biomarker-Informed Drug Interaction Evaluation in Drug Development and Regulatory Decision Making. [PDF]
The measurement of endogenous biomarkers in plasma and urine before and after administration of an investigational drug in a clinical study may provide an early indication of its drug–drug interaction (DDI) potential via a specific pathway. In the first international harmonized guideline on drug interaction studies, the International Council for ...
Ishiguro A +6 more
europepmc +2 more sources
Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions [PDF]
The current BSC guidance issued by the FDA allows for biowaivers based on conservative criteria. Possible new criteria and class boundaries are proposed for additional biowaivers based on the underlying physiology of the gastrointestinal tract. The proposed changes in new class boundaries for solubility and permeability are as follows: 1.
Polli, James E. +10 more
openaire +3 more sources
IN VITRO EQUIVALENCE STUDY OF GENERIC METFORMIN HYDROCHLORIDE TABLETS UNDER BIOWAIVER CONDITIONS [PDF]
Background: Generic drugs are smarter alternative to expensive brands, it is bio- equivalent formula of any branded drug. FDA approved that generic drugs are the safest to consume, the medicines meet the similar manufacturing standards followed while ...
Soubra, Lama +3 more
core +1 more source

